Eukaryotic Nucleoprotein, SARS-CoV (NP)

N Protein

  • Eukaryotic Nucleoprotein, SARS-CoV (NP) Packages (Simulation)
  • Eukaryotic Nucleoprotein, SARS-CoV (NP) Packages (Simulation)
  • Eukaryotic Nucleoprotein, SARS-CoV (NP) Figure . Gene Sequencing (extract)
  • EPX274Ge61.jpg Figure. SDS-PAGE
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

SEQUENCE of the Eukaryotic Nucleoprotein, SARS-CoV (NP)

USAGE of the Eukaryotic Nucleoprotein, SARS-CoV (NP)

Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

STORAGE of the Eukaryotic Nucleoprotein, SARS-CoV (NP)

Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

STABILITY of the Eukaryotic Nucleoprotein, SARS-CoV (NP)

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Related products

Catalog No. Organism species: Pan-species (General) Applications (RESEARCH USE ONLY!)
EPX274Ge62 Eukaryotic Nucleoprotein, SARS-CoV (NP) Positive Control; Immunogen; SDS-PAGE; WB.
RPX274Ge01 Recombinant Nucleoprotein, SARS-CoV (NP) Positive Control; Immunogen; SDS-PAGE; WB.
EPX274Ge61 Eukaryotic Nucleoprotein, SARS-CoV (NP) Positive Control; Immunogen; SDS-PAGE; WB.
PAX274Ge02 Polyclonal Antibody to Nucleoprotein, SARS-CoV (NP) WB; IHC; ICC; IP.
GUESTBOOK